Freeline Therapeutics (Biotechnology) Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 55

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

Freeline Therapeutics (Biotechnology) General Information

Description

Developer of gene therapies intended to improve the lives of people dealing with chronic debilitating diseases. The company specializes in CMC process, adeno-associated virus (AAV) development, analytics and advances in clinical programs in Fabry disease and Gaucher disease type 1.

Contact Information

Formerly Known As
VBB GmbH, Ascend Gene and Cell Therapies GmbH
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Fraunhoferstraße 9b
  • 82152 Planegg
  • Germany
+49 089
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Ascend (Drug Discovery)
Vertical(s)
Life Sciences
Corporate Office
  • Fraunhoferstraße 9b
  • 82152 Planegg
  • Germany
+49 089

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Freeline Therapeutics (Biotechnology) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Freeline Therapeutics (Biotechnology)‘s full profile, request access.

Request a free trial

Freeline Therapeutics (Biotechnology) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Freeline Therapeutics (Biotechnology) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Freeline Therapeutics (Biotechnology)‘s full profile, request access.

Request a free trial

Freeline Therapeutics (Biotechnology) FAQs

  • When was Freeline Therapeutics (Biotechnology) founded?

    Freeline Therapeutics (Biotechnology) was founded in 2015.

  • Where is Freeline Therapeutics (Biotechnology) headquartered?

    Freeline Therapeutics (Biotechnology) is headquartered in Planegg, Germany.

  • What is the size of Freeline Therapeutics (Biotechnology)?

    Freeline Therapeutics (Biotechnology) has 55 total employees.

  • What industry is Freeline Therapeutics (Biotechnology) in?

    Freeline Therapeutics (Biotechnology)’s primary industry is Drug Discovery.

  • Is Freeline Therapeutics (Biotechnology) a private or public company?

    Freeline Therapeutics (Biotechnology) is a Private company.

  • What is the current valuation of Freeline Therapeutics (Biotechnology)?

    The current valuation of Freeline Therapeutics (Biotechnology) is .

  • What is Freeline Therapeutics (Biotechnology)’s current revenue?

    The current revenue for Freeline Therapeutics (Biotechnology) is .

  • Who are Freeline Therapeutics (Biotechnology)’s investors?

    Spur Therapeutics has invested in Freeline Therapeutics (Biotechnology).

  • When was Freeline Therapeutics (Biotechnology) acquired?

    Freeline Therapeutics (Biotechnology) was acquired on 10-Feb-2023.

  • Who acquired Freeline Therapeutics (Biotechnology)?

    Freeline Therapeutics (Biotechnology) was acquired by Ascend (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process